{
  "docId": "019de076-3deb-7779-9c43-c38f834a1cfd",
  "docSlug": "60ad9a5894e93b6af8b1b5bddd2d87e3",
  "documentTitle": "Fusion Pharmaceuticals | Investor Presentation Deck | 30 slides",
  "authorId": "fusion-pharmaceuticals",
  "authorName": "Fusion Pharmaceuticals",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 3,
  "pageCount": 30,
  "prevPage": 2,
  "nextPage": 4,
  "slideType": "why_now",
  "function": "argue_timing",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "The slide uses a combination of bulleted benefits and a visual process diagram to explain the mechanism of action.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-3deb-7779-9c43-c38f834a1cfd/3",
  "deckHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd",
  "deckJsonHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd.json",
  "deckAnchorHref": "/decks/019de076-3deb-7779-9c43-c38f834a1cfd#slide-3",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.5,
        "x": 0.48,
        "y": 0.15
      },
      "kind": "diagram",
      "text": "Targeted Alpha Therapy: Targeting molecule + a medical isotope",
      "attrs": null,
      "subkind": "process",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cc4a5953-6630-4211-adaf-69cbfdaacf37",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.4,
        "w": 0.5,
        "x": 0.48,
        "y": 0.25
      },
      "kind": "image",
      "text": null,
      "attrs": null,
      "subkind": "illustration",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "4f1755c4-6930-4591-a0b9-eb110d9f17bd",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.7,
        "w": 0.45,
        "x": 0.03,
        "y": 0.15
      },
      "kind": "list",
      "text": "Approach systemically delivers radiation directly to tumor cells; Simple, proven MOA to kill cancer cells through direct DNA damage; Opportunity to address unmet medical needs; True precision medicine; Technology advancements and clinical data surge.",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "ab8e44ac-90ba-487a-9260-31128f55d687",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 1,
        "x": 0,
        "y": 0.9
      },
      "kind": "title",
      "text": "Radiopharmaceuticals are poised to become one of the primary pillars of modern cancer therapy",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c28f2ef5-72c2-438f-8ac6-0e3e9f279b49",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.4,
        "x": 0.03,
        "y": 0.03
      },
      "kind": "title",
      "text": "Radiopharmaceutical Resurgence",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "467634cd-67b6-4ff2-aa30-83683fd1d5be",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Action Titles",
      "slug": "action-titles",
      "agent": "Architect",
      "layer": "slide",
      "matchId": "23b9c90d-0d60-42c9-96d3-89f2e78bd6b5",
      "evidence": "The title 'Radiopharmaceuticals are poised to become one of the primary pillars of modern cancer therapy' is an action title.",
      "confidence": 0.8
    },
    {
      "name": "Aha! Moment",
      "slug": "aha-moment",
      "agent": "Storyteller",
      "layer": "slide",
      "matchId": "a38c8780-c36e-4c32-8336-212c5153f626",
      "evidence": "This slide presents a key insight: 'Radiopharmaceuticals are poised to become one of the primary pillars of modern cancer therapy'.",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 5,
      "from": 3,
      "beatId": "bf4c6577-ee3e-4666-8cc2-b252ab138221",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Problem",
      "beatSlug": "sequoia-pitch-problem",
      "evidence": "The document highlights the growing importance of radiopharmaceuticals in cancer therapy and the limitations of current treatments",
      "position": 0,
      "confidence": 0.8,
      "parentBeatName": "Complication",
      "parentBeatSlug": "complication"
    }
  ],
  "loops": [
    {
      "to": 5,
      "from": 3,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "63f52651-897c-47e3-a629-7d503894345b",
      "evidence": "The document presents a clear and compelling case for why radiopharmaceuticals are poised to become a primary pillar of modern cancer therapy",
      "position": 0,
      "objective": "Why now is the right time for radiopharmaceuticals",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.8,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}